Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.
George Freeman MP, minister of state at the new Department for Science, Innovation and Technology, has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.
As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.
The check-in with nearly 1,800 US healthcare consumers reflects how COVID-19 and other factors have impacted patient access, equity, experience and trust.
SGS’ OneVision initiative is working to standardize record-keeping across the global life sciences industry in an aim to accelerate laboratory testing, development, and eliminate paper-based systems.
Artificial intelligence tools will allow the pharmaceutical companies to make predictions about diseases more effectively than before, says ImaginAB’s CEO.
CPhI North America donates $10,000 to iBIO’s Educate Center to help fund STEM programs for girls and solidifies its partnership with the association to support Illinois as a growing life sciences hub.
JSR Corporation has acquired Crown Bioscience for more than $405m – the company’s largest investment to date as it turns its attention towards preclinical support for biopharma, says Life Sciences president.
Parexel has partnered with Microsoft to advance patient-centric technologies and help deliver on the promise of personalized medicine following a need for efficiency and innovation in drug development.
GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.
As clinical trials “continue to shift to emerging markets,” the translation company Welocalize has acquired Global Language Solutions (GLS) to further support its clients’ linguistic validation processes.
Outsourcing-Pharma presents its round-up of the movers and shakers within the pharmaceutical industry, including news from PPD, Omnicare, and Bio Nebraska.
Microsoft is ramping up its efforts in drug R&D for personalised medicine through the acquisition of genomic analysis technology developed by Seattle, US firm Rosetta Biosoftware.
Massachusetts needs to do more to produce workers for its life sciences industry if it is to avoid a skills shortage in years to come, according to research.
LabTechnologist.com brings you an exclusive interview with Ger
Brophy - general manager of Advanced Systems within GE Healthcare's
Life Science Division.
European life sciences received an unexpected boost as the European
Science Foundation launched an initiative to help promote and
coordinate interaction among European life sciences researchers and
funders.
Court Square, a provider of IT service offerings for both large and
small biopharma firms, has seized upon what it saw as a gap in the
market to open up a dedicated life sciences division for small and
medium-sized companies (SMEs).
Japanese health care firm Eisai will make Hatfield its European
headquarters, in a major £75 million (€105 million) investment that
demonstrates the UK's appeal for big pharmaceutical companies.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Life sciences is to be given priority under a European Commission
(EU) framework, which focuses on creating a knowledge-based economy
to ensure increased funding for this industry.
Life sciences investment group Abingworth Management has announced
the initial Abingworth BioEquities Fund (ABE) has raised $53
million (€44 million) to invest across the life sciences field
including human therapeutics.
The boundary between the pharma and biotech industries will become
incresingly blurred over the next 10 years, with the latter
enjoying stronger growth, writes Phil Taylor.
Emerson Process Management has stepped up its efforts to sell its
engineering, process control and digital automation technologies
into the life sciences sector with the launch of a new programme,
called OpX, at the Interphex exhibition...
France's drug industry has started filling in the detail of its
strategic plan to boost the standing of the biotechnology sector,
first unveiled at the end of last month. At the heart of the plans
is a quadrupling of the production...
Purification and filtration systems manufacturer Pall has reported
flat fiscal fourth-quarter earnings that missed analysts'
expectations, although group sales grew by 7 per cent to $504.5
million (€418m).
The enlargement of the European Union to include 10 new countries
has raised fears about the impact this could have on issues such as
parallel imports and intellectual property protection, but it could
reinvigorate the industry in...
In its first progress report since adopting the EU strategy on life
sciences and biotechnology in 2002, the European Commission
yesterday indicated that the risk of diverging policies in Member
States could seriously hamper the effectiveness...
